Egle Therapeutics

Healthcare & Life Sciences

Recent Finacing

Non-dilutive financing

Recent Raise

$10.2M

Egle Therapeutics is a biotechnology company developing therapies targeting regulatory T cells for cancer and autoimmune diseases.